SMRIvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with SMRI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
SMRI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/18/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | SMRI ETF 2 | -0.93%– | +15.40%– | +30.38%– | +37.29%– | +94.48%– | n/a– |
| Flows | SMRI ETF 2 | +$13M– | +$24M– | +$42M– | +$54M– | +$179M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | SMRI ETF 2 | +13.88%– | +15.16%– | +15.89%– | n/a– |
| Max drawdown | SMRI ETF 2 | -4.66%– | -6.80%– | -18.43%– | n/a– |
| Max drawdown duration | SMRI ETF 2 | 15d– | 95d– | 204d– | n/a– |
Trading data
SMRI | ETF 2 | |
Last sale 9/18/2026 at 1:30 PM | $46.97 | – |
| Previous close 09/17/2026 | $47.59 | – |
| Consolidated volume 09/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/18/2026 at 1:30 PM
Live
Closed
SMRI | ETF 2 | |
|---|---|---|
| Last price | $46.97 | – |
| 1D performance | -1.30% | – |
| AuM | $700.65 M | – |
| E/R | 0.71% | – |
Characteristics
SMRI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Alpha Architect | – |
| Benchmark | - | – |
| N° of holdings | - | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 14, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
SMRI
Data will be available soon
ETF 2
Sectors
SMRI
Data will be available soon
ETF 2
Advertisement
Diversification
SMRI
Data will be available soon
ETF 2
–
Top 15 holdings
Data as of January 1, 1970
SMRI
Data will be available soon
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
